Naveen M. Kulkarni

Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).

Purpose:Our aim was to investigate the hypothesis that the CT perfusion (CTP) is a more sensitive image biomarker when compared with tumor burden (Response Evaluation Criteria in Solid Tumors [RECIST]) and tumor density (HU) for monitoring treatment changes and for predicting long-term outcome in advanced hepatocellular carcinoma (HCC) treated with a combination of antiangiogenic treatment and chemotherapy. Material and Methods:In this phase II clinical trial, 33 patients with advanced HCC were enrolled and 23 were included in the current study. A diagnostic dual-phase contrast-enhanced CT and perfusion CT was performed at baseline and days 10 to 12 after initiation of antiangiogenic treatment (Bevacizumab). The patients subsequently received bevacizumab in combination with gemcitabine and oxaliplatin (GEMOX-B) and contrast-enhanced CT was performed at the end of treatment (after completing 3 cycles of GEMOX-B chemotherapy) and after every 8 week until there was evidence of disease progression or intolerable toxicity. The CTP protocol included a targeted dynamic cine acquisition for 25 to 30 seconds after 50 to 70 mL of iodinated contrast media injection at 5 to 7 mL/s. The CTP parameters were compared with tumor size (according to Response Evaluation Criteria in Solid Tumors, RECIST 1.1) and density measurements (HU) before and after treatment and correlated with patients outcome in groups with and without tumor thrombus. A one-sided P value was calculated and the Bonferroni correction was used to address the issue of multiple comparisons. Results:On days 10 to 12 after initiation of bevacizumab, significant decrease in CTP parameters was noted (P < 0.005). There was a mild reduction in mean tumor density (P = 0.016) without any significant change in mean tumor size. Tumors with higher baseline mean transit time values on CTP correlated with favorable clinical outcome (partial response and stable disease) and had better 6 months progression-free survival (P = 0.002 and P = 0.005, respectively). The baseline transfer constant (Ktrans) of responders (1425.19 ± 609.47 mL/1000 mL/min) was significantly higher than that of nonresponders (935.96 ± 189.47 mL/1000 mL/min). The tumor thrombus in the portal vein demonstrated baseline perfusion values and post-treatment change values similar to the HCC. Conclusion:In advanced HCC, CTP is a more sensitive image biomarker for monitoring early antiangiogenic treatment effects as well as in predicting outcome at the end of treatment and progression-free survival as compared with RECIST and tumor density.

Low-Dose MDCT and CT Enterography of Patients With Crohn Disease: Feasibility of Adaptive Statistical Iterative Reconstruction

OBJECTIVE The purpose of this study was to evaluate the image quality and diagnostic performance of low-dose MDCT and CT enterography with adaptive statistical iterative reconstruction (ASIR) in the evaluation of Crohn disease. SUBJECTS AND METHODS Forty-eight patients (20 men, 28 women; mean age, 33.3 years; range, 17-83 years) with known or suspected Crohn disease who underwent low-dose MDCT and CT enterography with ASIR between December 2008 and December 2009 were included in the study. Twenty-seven patients had previously undergone standard-dose 64-MDCT and CT enterography with filtered back projection (FBP), and those images were used for comparison. The weight-based i.v. contrast protocol and scan parameters (120 kVp, 5-mm section thickness, 0.5-second rotation, pitch of 1.375, 64 × 0.625 mm detector configuration) were constant for the two techniques except for a higher noise index (×1.3) in the ASIR group. Two blinded readers reviewed 75 randomized MDCT-CT enterographic scans of 48 patients to assess image quality and diagnostic performance in the evaluation of Crohn disease, and the radiation dose for the studies was estimated. RESULTS All 75 MDCT and CT enterographic scans had acceptable quality for diagnostic interpretation. Findings of Crohn disease were seen on 63 of 75 scans (84%). Low-dose scans in the ASIR group had optimal image quality and were rated comparable to or better than standard-dose FBP images (mean score, 4.2 vs 3.87; p = 0.007). The subjective image noise score (mean, 1.43 vs 1.58; p = 0.2) and objective image noise measurements were lower for ASIR images (p < 0.001). Low-dose studies with ASIR allowed average dose reduction of 34.5% compared with standard-dose scans with FBP (volume CT dose index for ASIR, 7.7 ± 2.1 mGy; for FBP, 12 ± 5.5 mGy; p < 0.01). CONCLUSION Low-dose MDCT and CT enterographic studies reconstructed with ASIR were of appropriate quality for confident evaluation of the manifestations of Crohn disease while allowing approximately 34% dose reduction in comparison with FBP technique.

Oncologic Applications of Dual-Energy CT in the Abdomen

Dual-energy computed tomographic (DECT) technology offers enhanced capabilities that may benefit oncologic imaging in the abdomen. By using two different energies, dual-energy CT allows material decomposition on the basis of energy-dependent attenuation profiles of specific materials. Although image acquisition with dual-energy CT is similar to that with single-energy CT, comprehensive postprocessing is able to generate not only images that are similar to single-energy CT (SECT) images, but a variety of other images, such as virtual unenhanced (VUE), virtual monochromatic (VMC), and material-specific iodine images. An increase in the conspicuity of iodine on low-energy VMC images and material-specific iodine images may aid detection and characterization of tumors. Use of VMC images of a desired energy level (40-140 keV) improves lesion-to-background contrast and the quality of vascular imaging for preoperative planning. Material-specific iodine images enable differentiation of hypoattenuating tumors from hypo- or hyperattenuating cysts and facilitate detection of isoattenuating tumors, such as pancreatic masses and peritoneal disease, thereby defining tumor targets for imaging-guided therapy. Moreover, quantitative iodine mapping may serve as a surrogate biomarker for monitoring effects of the treatment. Dual-energy CT is an innovative imaging technique that enhances the capabilities of CT in evaluating oncology patients.

Determination of renal stone composition in phantom and patients using single-source dual-energy computed tomography.

Purpose This study aimed to characterize the urinary tract stones in phantom and patients using single-source dual-energy computed tomography. Materials and Methods Twenty stones of pure crystalline composition (uric acid [UA], struvite, cystine, and calcium oxalate monohydrate) were assessed in a phantom and 11 patients (age 39–67 years) with urinary tract stones were evaluated. An initial low-dose unenhanced CT (tube potential, 120 kilovolts [peak]; milliampere range, 150–450; noise index, 26; section thickness, 5 mm) followed by a targeted dual-energy computed tomography acquisition on a single-source dual-energy computed tomography (Discovery CT 750 HDCT, GE) was performed. Uric acid and non-UA stones were defined using a 2-material decomposition (material density–iodine/water) algorithm. The stone effective atomic number (Zeff) was used to subclassify non-UA stones. The stone attenuation (Hounsfield unit) was also studied to determine its performance in predicting the composition. Ex vivo chemical analysis of the stone served as a criterion standard. Results Of the 59 verified stones (phantom, 20; patients, 39; mean size, 6 mm), there were 16 UA and 43 non-UA type. The material density images were 100% sensitive and accurate in detecting UA and non-UA stones. The Zeff accurately stratified struvite, cystine, and calcium (calcium oxalate monohydrate) stones in the phantom. In patients, Zeff identified 83% of calcium stones (n = 24), and in stones of mixed type, it resembled dominant composition. The Hounsfield unit measurements alone were 71% sensitive and 69% accurate in detecting the UA stones. Conclusions Single-source dual-energy computed tomography can accurately predict UA and non-UA stone composition in vitro and in vivo. Substratification of non-UA stones of pure composition can be made in vitro and in vivo. In stones of mixed composition, the Zeff values reflect the dominant composition.

Causes of renal forniceal rupture

Study Type – Diagnostic (exploratory cohort) Level of Evidence 2b

Emerging Technologies in CT- Radiation Dose Reduction and Dual-Energy CT

Part I: Strategies for Reducing Radiation exposure in Abdomen Multidetector Computed Tomography (MDCT) CT is indispensable to the modern management of patients with variety of abdomen and pelvic diseases. Imaging of the abdominal and pelvis alone contributes up to 32% of all CT examinations. Relatively higher radiation dose delivered by abdominal and pelvis CT in comparison with other body regions, the presence of many radiosensitive organs in the field, and increased utilization of abdomen and pelvic CT have raised concerns of potential cancer risks from radiation exposure. In one series, it was shown that a single-acquisition abdomen and pelvis CT with median effective dose of 15 mSv (range, 10-20 mSv) if performed at age 3 is associated with mean lifetime cancer risk up to 20 cancers per 10,000 CT examinations, declining to 3 cancers per 10,000 CT examinations when exposed at 70 years of age. This has raised concern not only among radiologists, but also among ordering physicians and patients referred for CT examination. In this section, we provide strategies for reducing cumulative radiation dose to patients undergoing abdomen-pelvis CT examination while maintaining diagnostic image quality for the required task.

Indirect Computed Tomography Venography of the Lower Extremities Using Single-Source Dual- Energy Computed Tomography: Advantage of Low-Kiloelectron Volt Monochromatic Images

PURPOSE To study the performance of dual-energy indirect computed tomography (CT) venography from single-source dual-energy CT in the assessment of lower extremity deep venous thrombosis (DVT). MATERIALS AND METHODS In a retrospective study, 110 patients suspected to have pulmonary embolism (PE) underwent dual-energy CT venography on a single-source dual-energy CT scanner as a part of CT pulmonary angiography protocol at 3 minutes after injection of contrast material. Two radiologists evaluated 50-kiloelectron volt (keV) and 70-keV monochromatic images reconstructed from a dual-energy CT scan for image quality, image noise, venous contrast, and confidence level in interpretation for DVT using a scale of 1-5. In addition, a combined 50-keV and 70-keV data set was assessed for confidence level in image interpretation. Attenuation, contrast-to-noise ratio (CNR), and objective noise were measured in bilateral common femoral and popliteal veins. Data were analyzed using Student t test and Wilcoxon rank sum test. Radiation dose was measured for dual-energy CT venography protocol. RESULTS A diagnosis of DVT was made in 8 of 110 patients (7.27%). The subjective image quality was comparable between 50-keV and 70-keV images (4.3 vs 4.5; P > .05). The subjective venous contrast opacification (4.7 vs 3.5; P = .0036) and confidence (4.8 vs 3.9; P = .0028) in image interpretation were superior at 50 keV. Confidence level for interpretation on combined 50-keV and 70-keV series (score 4.7) was similar to that for 50-keV series (score 4.8). Compared with 70-keV data, 50-keV data yielded 90% increase in intravascular CT attenuation (207.4 Hounsfield units [HU] ± 39.0 vs 106.8 HU ± 7.6; P <.0001) and higher CNR (10.7 ± 4.07 vs 7.2 ± 4.1; P = .0001) of the deep veins. However, objective noise at 50 keV was higher (14.8 HU vs 6.5 HU; P = .0031). Because of inadequate contrast opacification, 6% of CT venography studies were deemed suboptimal for rendering a diagnostic interpretation on 70-keV images, but these images were considered acceptable at 50 keV. The mean effective radiation dose for the dual-energy CT venography examination was 4.2 mSv. CONCLUSIONS Optimal image quality with substantially higher venous attenuation is provided by 50-keV monochromatic images from dual-energy CT venography acquisition compared with 70-keV images. The 50-keV monochromatic images increase the confidence in the image interpretation of DVT and decrease the number of indeterminate studies.

Effective atomic number accuracy for kidney stone characterization using spectral CT

The clinical application of Gemstone Spectral ImagingTM, a fast kV switching dual energy acquisition, is explored in the context of noninvasive kidney stone characterization. Utilizing projection-based material decomposition, effective atomic number and monochromatic images are generated for kidney stone characterization. Analytical and experimental measurements are reported and contrasted. Phantoms were constructed using stone specimens extracted from patients. This allowed for imaging of the different stone types under similar conditions. The stone specimens comprised of Uric Acid, Cystine, Struvite and Calcium-based compositions. Collectively, these stone types span an effective atomic number range of approximately 7 to 14. While Uric Acid and Calcium based stones are generally distinguishable in conventional CT, stone compositions like Cystine and Struvite are difficult to distinguish resulting in treatment uncertainty. Experimental phantom measurements, made under increasingly complex imaging conditions, illustrate the impact of various factors on measurement accuracy. Preliminary clinical studies are reported.

New and Evolving Concepts in CT for Abdominal Vascular Imaging

Computed tomographic (CT) angiography has become the standard of care, supplanting invasive angiography for comprehensive initial evaluation of acute and chronic conditions affecting the vascular system in the abdomen and elsewhere. Over the past decade, the capabilities of CT have improved substantially; simultaneously, the expectations of the referring physician and vascular surgeons have also evolved. Increasingly, CT angiography is used as an imaging biomarker for treatment selection and assessment of effectiveness. However, the growing use of CT angiography has also introduced some challenges, as potential radiation-associated and contrast media-induced risks need to be addressed. These concerns can be partly confronted by modifying scanning parameters (applying a low tube voltage) with or without using software-based solutions. Most recently, multienergy technology has endowed CT with new capabilities offering improved CT angiographic image quality and novel plaque characterization while decreasing radiation and iodine dose. In this article, we discuss current and new approaches using both conventional and multienergy CT for studying vascular disease in the abdomen. We propose various approaches to overcoming commonly encountered image quality challenges in CT angiography. In addition, we describe supplemental strategies for improving patient safety that leverage the available technology.

Dose reduction for chest CT: comparison of two iterative reconstruction techniques

Background Lowering radiation dose in computed tomography (CT) scan results in low quality noisy images. Iterative reconstruction techniques are used currently to lower image noise and improve the quality of images. Purpose To evaluate lesion detection and diagnostic acceptability of chest CT images acquired at CTDIvol of 1.8 mGy and processed with two different iterative reconstruction techniques. Material and Methods Twenty-two patients (mean age, 60 ± 14 years; men, 13; women, 9; body mass index, 27.4 ± 6.5 kg/m2) gave informed consent for acquisition of low dose (LD) series in addition to the standard dose (SD) chest CT on a 128 - multidetector CT (MDCT). LD images were reconstructed with SafeCT C4, L1, and L2 settings, and Safire S1, S2, and S3 settings. Three thoracic radiologists assessed LD image series (S1, S2, S3, C4, L1, and L2) for lesion detection and comparison of lesion margin, visibility of normal structures, and diagnostic confidence with SD chest CT. Inter-observer agreement (kappa) was calculated. Results Average CTDIvol was 6.4 ± 2.7 mGy and 1.8 ± 0.2 mGy for SD and LD series, respectively. No additional lesion was found in SD as compared to LD images. Visibility of ground-glass opacities and lesion margins, as well as normal structures visibility were not affected on LD. CT image visibility of major fissure and pericardium was not optimal in some cases (n = 5). Objective image noise in some low dose images processed with SafeCT and Safire was similar to SD images (P value > 0.5). Conclusion Routine LD chest CT reconstructed with iterative reconstruction technique can provide similar diagnostic information in terms of lesion detection, margin, and diagnostic confidence as compared to SD, regardless of the iterative reconstruction settings.